Partnering opportunity

Nanoparticles doped with copper for magnetic resonance imaging

Summary

A Spanish research institution has developed a new family of nanoparticles with interesting properties for Magnetic Resonance Imaging (MRI). These non-toxic nanoparticles can be used as positive contrast agents and are obtained in a simple, fast and reproducible manufacturing procedure. They are looking for partners, with no preferred location, to establish a license or research cooperation agreement.

Partner sought

The Research center is seeking for companies working as agents for medical imaging for out-licensing the patent. The partner would further develop the technology (either on its own or with the help of the center through an R&D collaboration agreement) and/or commercialize it, in case that the collaboration is vehiculated through a license agreement.

Description

In magnetic resonance imaging (MRI), the majority of nanoparticles (NP) based on iron oxide provide a negative (T2) signal which results in the area where these NPs accumulate to appear in black color. For several reasons, such color complicates the diagnosis and thus limits its clinical use. Therefore, research is searching for NPs generating contrast based in the longitudinal relaxation time (T1), which renders a brightening of the image upon the accumulation of the probe. The search for new iron oxide nanoparticle-based probes for MRI has moved to the development of iron oxide nanoparticles (IONP) as ‘positive’ contrast agents, showing large values of their longitudinal relaxivity (r1), a value that measures the capacity of a contrast agent to provide a bright signal. A Spanish research institution has developed copper-doped iron oxide nanoparticles (CuIONP) capable of providing good contrast in T1. When iron oxide nanoparticles are doped with Cu (copper), a significant increase in the value of r1 is achieved. ‘Normal’ values of contrast agents for clinical use have values in the 4-6 range. In contrast, Cu-doped iron oxide nanoparticles, provide values of 16 mM-1s-1. In addition, the synthesis of these nanoparticles can be achieved in a simple, reproducible and controlled manner, which facilitates Good Manufacturing Practice (GMP), required for clinical use. The new nanomaterial has been fully characterized and demonstrated its in vivo use for the enhanced diagnosis of tumors in animal models. The research center is looking to establish a research cooperation agreement and/or license with companies working in medical imaging for further development (in case of research cooperation) and exploitation of their technology (in case of licensing).

Advantages and innovations

• A small amount of Cu has a significant increase in r1, achieving values of 16 mM-1s-1. • The final particles are obtained using microwave-driven synthesis (MWS) in a 10 minutes one-pot synthesis. This methodology can produce, in extremely short times, homogeneous nanoparticles with excellent properties for molecular imaging. • Nanometric size iron oxides have already been approved by the Food and Drug Administration (FDA) and other regulatory agencies. • The nanoparticle components, both iron oxide, and copper are non-toxic. • The new nanomaterial has been fully characterized and demonstrated its in vivo use for the enhanced diagnosis of tumors in animal models.

Development stage

Field tested/evaluated

Intellectual Property Rights (IPR)

Patent(s) applied for but not yet granted


Register your interest

How it works

  • Tell us about yourself
  • We’ll discuss with you
  • We put the right partners in touch

EEN help you find the right partner, rather than you going it alone.

Our role is to review and collate the most suitable submissions, and then send them to the client who posted the opportunity. We consult with you, and the client, to make the process professional and easy.

These are live opportunities. Your registration of interest on the site is just like a professional approach to a business at a networking event. To stand the best chance of success, make your submission really sing. Sell why the client who posted the opportunity should work with you. Excite them. Ask questions. Try and avoid copy and pasting words from elsewhere.

Once the client has chosen their partner, we'll introduce them over email and keep in touch with both parties to see how it's going. Sometimes things progress quickly. Sometimes because of changing priorities for either party, things progress slowly, but you never know - your next big business break could start right here.

?What value does EEN add?
This is your pitch: remember to include your unique selling points (USP) and why someone would want to do business with you
Tell us why you are a good fit for this opportunity, and why you think you're the right people for this partnership
If there's anything additional, or commercially sensitive you'd like to know about this opportunity, please let us know

When you entered your email address above, we emailed you a code to verify you're human and have access to that account.

?What's this?

What next?

To finish up, we just need some extra details about you and your company